Evaluation of the Living Kidney Donor: Current Perspectives

American Journal of Kidney Diseases

Volumn 43, Issue 3, 2004, Pages 508-530

  Davis, Connie L ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Box 356174 ^*  (United States)

Author keywords

Evaluation; Kidney transplantation; Living donor

Indexed keywords

ALBUMIN; ANTINUCLEAR ANTIBODY; COLLAGEN TYPE 4; CREATININE; CRYOGLOBULIN; CYTOKINE; GLUCOSE; HLA ANTIGEN; IMMUNOGLOBULIN A; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LAMININ; NITROGEN; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UREA;

BLOOD PRESSURE MONITORING; COMPUTER ASSISTED TOMOGRAPHY; CREATININE CLEARANCE; ECHOGRAPHY; GLOMERULUS FILTRATION RATE; HEPATITIS B; HEPATITIS C; HLA TYPING; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; KIDNEY POLYCYSTIC DISEASE; KIDNEY SCINTISCANNING; KIDNEY TRANSPLANTATION; LIVING DONOR; NEPHRECTOMY; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRACTICE GUIDELINE; PROTEINURIA; RENOVASCULAR DISEASE; REVIEW; SICKLE CELL TRAIT; SMOKING; SURGICAL RISK;

EID: 1542377645     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.10.044     Document Type: Article

References (143)

1. Wolfe RA, Ashby VB, Milford EL, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725-1730, 1999
2. Kasiske BL, Synder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT: Preemptive kidney transplantation: The advantage and the advantaged. J Am Soc Nephrol 13:1358-1364, 2002
3. Meier-Kriesche HU, Kaplan B: Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 74:1377-1381, 2002
4. Brunkhorst R, Lufft V, Dannenberg B, Kliem V, Tusch G, Pichlmayr R: Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: A case-control study. Transplantation 76:115-119, 2003
5. Roake JA, Cahill AP, Gray CM, Gray DW, Morris PJ: Preemptive cadaveric renal transplantation-Clinical outcome. Transplantation 62:1411-1416, 1996
6. Mange KC, Joffe MM, Feldman HI: Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344:726-731, 2001
7. Bia MJ, Ramos EL, Danovitch GM, et al: Evaluation of living renal donors. The current practice of US transplant centers. Transplantation 60:322-327, 1995
8. Gabolde M, Herve C, Moulin AM: Evaluation, selection, and follow-up of live kidney donors: A review of current practice in French renal transplant centres. Nephrol Dial Transplant 16:2048-2052, 2001
9. Lumsdaine JA, Wigmore SJ, Forsythe JLR: Liver kidney donor assessment in the UK and Ireland. Br J Surg 86:877-881, 1999
10. Fauchald P: Living donor kidney transplantation: Evaluation and selection of the donor. Transplant Proc 35:931-932, 2003
11. Gloor JM, Lager DJ, Moore SB, et al: ABO-Incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 75:971-977, 2003
12. Buhler L, Awwad M, Treter S, et al: Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD 154 blockade. Transplantation 73:12-22, 2002
13. Holechek MJ, Hiller JM, Paredes M, Rickard JC, Montgomery RA: Expanding the living organ donor pool: Positive crossmatch and ABO incompatible renal transplantation. Nephrol Nurs J 30:195-204, 2003
14. Vagefi PA, Yamamoto S, Kamano C, et al: Xenogeneic vascularized thymic lobe transplantation as a potential method of tolerance induction in a large animal model of pig-to-primate transplantation. Am J Transplant 3:1244A, 2003 (abstr)
15. Boulware LE, Ratner LE, Sosa JA, et al: The general public's concerns about clinical risk in live kidney donation. Am J Transplant 2:186-193, 2002
16. Delmonico FL, Harmon WE: The use of a minor as a live kidney donor. Am J Transplant 2:333-336, 2002
17. Ross LF: All donations should not be treated equally: A response to Jeffrey Kahn's commentary. J Law Med Ethics 30:448-451, 2002
18. Ross LF, Glannon W, Josephson M, Thistlethwaite JR: All living donors should not be treated equally. Transplantation 75:1762-1763, 2003
19. Steiner RW, Gert B: Ethical selection of living kidney donors. Am J Kidney Dis 36:677-686, 2000
20. Perry KT, Freedland SJ, Hu JC, et al: Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. J Urol 169:2018-2021, 2003
21. Ratner LE, Montgomery RA, Kavoussi LR: Laparoscopic live donor nephrectomy. A review of the first 5 years. Urol Clin North Am 28:709-719, 2001
22. Pradel FG, Limcangco MR, Mullins CD, Bartlett ST: Patients' attitudes about living donor transplantation and living donor nephrectomy. Am J Kidney Dis 41:849-858, 2003
23. Ellison MD, McBride MA, Edwards LB, et al: Living organ donation: Mortality and early complications among 16,395 living donors in the US. Am J Transplant 3:517A, 2003 (abstr)
24. Matas AJ, Leichtman AB, Bartlett ST, Delmonico FL: Kidney donor morbidity and mortality. Am J Transplant 2:2A, 2002 (abstr)
25. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625-1638, 2003
26. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S: Influence of smoking and obesity on the development of proteinuria. Kidney Int 62:956-962, 2002
27. Praga M, Hernandez E, Herrero JC, et al: Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58:2111-2118, 2000
28. Formica MK, Palmer JR, Rosenberg L, McAlindon TE: Smoking, alcohol consumption, and risk of systemic lupus erythematosus in the Black Women's Health Study. J Rheumatol 30:1222-1226, 2003
29. Boyle JP, Honeycutt AA, Narayan KM, et al: Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the US. Diabetes Care 24:1936-1940, 2001
30. Geiss LS, Herman WH, Goldschmid MG, et al: Surveillance for diabetes mellitus-United States, 1980-1989. MMWR Morb Mortal Wkly Rep 42:1-20, 1993
31. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al: Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective. J Pediatr 136:664-672, 2000
32. Tierney EF, Geiss LS, Engelgau MM, et al: Population-based estimate of mortality associated with diabetes: Use of a death certificate check box in North Dakota. Am J Public Health 91:84-92, 2001
33. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM: Estimated number of adults with prediabetes in the US in 2000: Opportunities for prevention. Diabetes Care 26:645-699, 2003
34. Abate N, Chandalia M: The impact of ethnicity on type 2 diabetes. J Diabetes Complications 17:39-58, 2003
35. O'Brien PE, Dixon JB: The extent of the problem of obesity. Am J Surg 184:S4-S8, 2002 (suppl)
36. Semenza JC, Ziogas A, Largent J, Peel D, Anton-Culver H: Gene-environment interactions in renal cell carcinoma. Am J Epidemiol 153:851-899, 2001
37. Dosemeci J, Cocco P, Chow WH: Gender differences in risk of renal cell carcinoma and occupational exposures to chlorinated aliphatic hydrocarbons. Am J Ind Med 36:54-59, 1999
38. Pesch B, Haerting J, Ranft U, Klimpel A, Oelschlagel B, Schill W: Occupational risk factors for renal cell carcinoma: Agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study. Int J Epidemiol 29:1014-1024, 2000
39. Buzio L, Tondel M, DePalma G, et al: Occupational risk factors for renal cell cancer. An Italian case-control study. Med Lav 93:303-309, 2002
40. Iseki K, Iseki C, Ikemiya Y, Fukiyama K: Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 49:800-805, 1996
41. Iseki K, Ikemiya Y, Iseki C, Takishita S: Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63:1468-1474, 2003
42. Lhotta K, Rumpelt HJ, Konig P, Mayer G, Kronenberg F: Cigarette smoking and vascular pathology in renal biopsies. Kidney Int 61:648-654, 2002
43. Briganti EM, Branley P, Chadban SJ, et al: Smoking is associated with renal impairment and proteinuria in the normal population: The AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 40:704-712, 2002
44. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134:629-636, 2001
45. Ruilope LM, Salvetti A, Jamerson K, et al: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 12:218-225, 2001
46. Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF: Renal function: The Cinderella of cardiovascular risk profile. J Am Coll Cardiol 38:1782-1787, 2001
47. Baudoin P, Provoost AP, Molenaar JC: Renal function up to 50 years after unilateral nephrectomy in childhood. Am J Kidney Dis 21:603-611, 1993
48. Silveiro SP, da Costa LA, Beck MO, Gross JL: Urinary albumin excretion rate and glomerular filtration rate in single-kidney type 2 diabetic patients. Diabetes Care 21:1521-1524, 1998
49. Narkun-Burgess DM, Nolan CR, Norman JE, Page WF, Miller PL, Meyer TW: Forty-five year follow-up after uninephrectomy. Kidney Int 43:1110-1115, 1993
50. Joint National Committee: Hypertension prevalence and the status of awareness, treatment, and control in the United States. Hypertension 7:457-468, 1985
51. Ramcharan T, Matas AJ: Long-term (20-37 years) follow-up of living kidney donors. Am J Transplant 2:959-964, 2002
52. Najarian JS, Chavers BM, McHugh LE, Matas AJ: 20 Years of more of follow-up of living kidney donors. Lancet 340:807-810, 1992
53. Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tyden G, Groth CG: Kidney donors live longer. Transplantation 64:976-978, 1997
54. Ellison MD, McBride MA, Taranto SE, Delmonico FL, Kauffman HM: Living kidney donors in need of kidney transplants: A report from the Organ Procurement and Transplantation Network. Transplantation 74:1349-1351, 2002
55. Torres VE, Offord KR Anderson CF, et al: Blood pressure determinants in living-related renal allograft donors and their recipients. Kidney Int 31:1383-1390, 1987
56. Ozdemir N, Guz G, Muderrisoglu H, et al: Ambulatory blood pressure monitoring in potential renal transplant donors. Transplant Proc 31:3369-3370, 1999
57. Textor SC, Taler SJ, Larson TS, et al: Blood pressure evaluation among older living kidney donors. J Am Soc Nephrol 14:2159-2167, 2003
58. Textor SC, Taler SJ, Prieto M, et al: Hypertensive living renal donors have lower blood pressures and urinary microalbumin one year after nephrectomy. Am J Transplant 3:192A, 2003 (abstr)
59. Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG, Gasbarrini G: HCV infection and extrahepatic manifestations. Hepatogastroenterology 50:1149-1154, 2003
60. El-Serag HB, Hampel H, Yeh C, Rabeneck L: Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36:1439-1445, 2002
61. McMurray RW, Elbourne K: Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 26:689-701, 1997
62. Johnson RJ, Gretch DR, Yamabe H, et al: Membrano-proliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465-470, 1993
63. Cacoub P, Poynard T, Ghillani P, et al: Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 42:2204-2212, 1999
64. Nagao Y, Hanada S, Shishido S, Kumashiro R, Ueno T, Sata M: Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection. J Gastroenterol Hepatol 18:258-266, 2003
65. Arase Y, Ikeda K, Murashima N, et al: Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med 37:836-840, 1998
66. Seeff LB: Natural history of hepatitis C. Am J Med 107:S10-S15, 1999 (suppl)
67. Gasparotto D, De Re V, Boiocchi M: Hepatitis C virus, B-cell proliferation and lymphomas. Leuk Lymphoma 43:747-751, 2002
68. Thuluvath PJ, John PR: Association between hepatitis C, diabetes mellitus, and race: A case-control study. Am J Gastroenterol 98:438-441, 2003
69. Mehta SH, Brancati FL, Strathdee SA, et al: Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38:50-56, 2003
70. Kohler PF, Cronin RE, Hammond WS, Olin D, Carr RI: Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Intern Med 81:448-451, 1974
71. Seedat YK: Glomerular disease in the tropics. Semin Nephrol 23:12-20, 2003
72. Shet T, Kandalkar B, Balasubramaniam M, Phatak A: The renal pathology in children dying with hepatic cirrhosis. Indian J Pathol Microbiol 45:39-43, 2002
73. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL: Association between polyarteritis and Australia antigen. Lancet 2:1149-1153, 1970
74. Goran MI, Ball GD, Cruz ML: Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 88:1417-1427, 2003
75. Gadsby R: Epidemiology of diabetes. Adv Drug Deliv Rev 54:1165-1172, 2002
76. Hanley AJ, Williams K, Gonzalez C, et al: Prediction of type 2 diabetes using simple measures of insulin resistance: Combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52:463-469, 2003
77. Hanson RL, Pratley RE, Bogardus C, et al: Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190-198, 2000
78. Li G, Hu Y, Yang W, et al: Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: The DA Qing IGT and Diabetes study. Diabetes Res Clin Pract 58:193-200, 2002
79. Linne Y, Barkeling B, Rossner S: Natural course of gestational diabetes mellitus: Long term follow up of women in the SPAWN study. Br J Obstet Gynaecol 109:1227-1231, 2002
80. Spranger J, Kroke A, Mohlig M, et al: Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817, 2003
81. Kubaszek A, Pihlajamaki J, Komarovski V, et al: Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: The Finnish Diabetes Prevention Study. Diabetes 52:1872-1876, 2003
82. Liao D, Asberry PJ, Shofer JB, et al: Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance. Diabetes Care 25:1504-1510, 2002
83. Tate DF, Jackvony EH, Wing RR: Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: A randomized trial. JAMA 289:1833-1836, 2003
84. Goldhaber-Fiebert JD, Goldhaber-Fiebert SN, Tristan ML, Nathan DM: Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica. Diabetes Care 26:24-29, 2003
85. Snitker S, Mitchell BD, Shuldiner AR: Physical activity and prevention of type 2 diabetes. Lancet 361:87-88, 2003
86. Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE: Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): Preliminary results after one year. Int J Obes Relat Metab Disord 27:377-384, 2003
87. Brekke HK, Jansson PA, Mansson JE, Lenner RA: Lifestyle changes can be achieved through counseling and follow-up in first-degree relatives of patients with type 2 diabetes. J Am Diet Assoc 103:835-843, 2003
88. Lee YH, Huang WC, Chang LS, Chen MT, Yang YF, Huang JK: The long-term stone recurrence rate and renal function change in unilateral nephrectomy urolithiasis patients. J Urol 152:1386-1388, 1994
89. Neymark E, LaBerge JM, Hirose R, et al: Arteriographic detection of renovascular disease in potential renal donors: Incidence and effect on donor surgery. Radiology 214:755-760, 2000
90. Cragg AH, Smith TP, Thompson BH, et al: Incidental fibromuscular dysplasia in potential renal donors: Long-term clinical follow-up. Radiology 172:145-147, 1989
91. Andreoni KA, Weeks SM, Gerber DA, et al: Incidence of donor renal fibromuscular dysplasia: Does it justify routine angiography? Transplantation 73:1112-1116, 2002
92. Indudhara R, Kenney, Bueschen AJ, Burns JR: Live donor nephrectomy in patients with fibromuscular dysplasia of the renal arteries. J Urol 162:678-681, 1999
93. Swartz MA, Karth J, Schneider DT, Rodriguez R, Beckwith JB, Perlman EJ: Renal medullary carcinoma: Clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology 60:1083-1089, 2002
94. Ataga KI, Orringer EP: Renal abnormalities in sickle cell disease. Am J Hematol 63:205-211, 2000
95. Sesso R, Almeida MA, Figueiredo MS, Bordin JO: Renal dysfunction in patients with sickle cell anemia or sickle cell trait. Braz J Med Biol Res 31:1257-1262, 1998
96. Herard A, Colin J, Youinou Y, Drancourt E, Brandt B: Massive gross hematuria in a sickle cell trait patient with renal papillary necrosis. Conservative approach using a balloon ureteral catheter to tamponade the papilla bleeding. Eur Urol 34:161-162, 1998
97. Zadeii G, Lohr JW: Renal papillary necrosis in a patient with sickle cell trait. J Am Soc Nephrol 8:1034-1039, 1997
98. Gupta AK, Kirchner KA, Nicholson R, et al: Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait. J Clin Invest 88:1963-1968, 1991
99. Hynd RF, Bharadwaja K, Mitas JA, Lord JT: Rhabdomyolysis, acute renal failure, and disseminated intravascular coagulation in a man with sickle cell trait. South Med J 78:890-891, 1985
100. Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR: Fixed and reproducible orthostatic proteinuria: Results of a 20-year follow-up study. Ann Intern Med 97:516-519, 1982
101. Robinson RR, Glover SN, Phillippi PS, Lecocq FR, Langelier PR: Fixed and reproducible orthostatic proteinuria. 1. Light microscopic studies of the kidney. Am J Pathol 39:291-306, 1961
102. Robinson RR, Ashworth CT, Glover SN, Phillippi PS, Lecocq FR, Langelier PR: Fixed and reproducible orthostatic proteinuria. 11. Electron microscopy study of renal biopsy specimens from five cases. Am J Pathol 39:405-417, 1961
103. Gonwa TA, Atkins C, Zhang YA, et al: Glomerular filtration rates in persons evaluated as living-related donors - Are our standards too high? Transplantation 55:983-985, 1993
104. Bertolatus JA, Goddard L: Evaluation of renal function in potential living kidney donors. Transplantation 71:256-260, 2001
105. Richards A, Goodship JA, Goodship TH: The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Curr Opin Nephrol Hypertens 11:431-435, 2002
106. Hellwage J, Jokiranta TS, Friese MA, et al: Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J Immunol 169:6935-6944, 2002
107. Remuzzi G, Galbusera M, Noris M, et al: von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolyfic uremic syndrome. Blood 100:778-785, 2002
108. Remuzzi G, Ruggenenti P, Codazzi D, et al: Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 359:1671-1672, 2002
109. Tsao BP, Grossman JM, Riemekasten G, et al: Familiality and co-occurrence of clinical features of systemic lupus erythematosus. Arthritis Rheum 46:2678-2685, 2002
110. Prahalad S, Shear ES, Thompson SD, Giannini EH, Glass DN: Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum 46:1851-1856, 2002
111. Corporaal S, Bijl M, Kallenberg CG: Familial occurrence of autoimmune diseases and autoantibodies in a Caucasian population of patients with systemic lupus erythematosus. Clin Rheumatol 21:108-113, 2002
112. Scolari F: Familial IgA nephropathy. J Nephrol 12:213-219, 1999
113. Scolari F: Inherited forms of IgA nephropathy. J Nephrol 16:317-320, 2003
114. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF: Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 57:1818-1835, 2000
115. Schena FP, Cerullo G, Rossini M, Lanzilotta SG, D'Altri C, Manno C: Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol 13:453-460, 2002
116. Caridi G, Bertelli R, Di Duca M, et al: Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 14:1278-1286, 2003
117. Pollak MR: The genetic basis of FSGS and steroid-resistant nephrosis. Semin Nephrol 23:141-146, 2003
118. D'Agati V: Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 23:117-134, 2003
119. Lowik MM, Levtchenko EN, Monnens LA, van den Heuvel LP: WT-1 and NPHS2 mutation analysis in patients with non-familial steroid-resistant focal-segmental glomerulosclerosis. Clin Nephrol 59:143-146, 2003
120. Frasca GM, Onetti-Muda A, Renieri A: Thin glomerular basement membrane disease. J Nephrol 13:15-19, 2000
121. Lemmink HH, Schroder CH, Monnens LA, Smeets HJ: The clinical spectrum of type IV collagen mutations. Hum Mutat 9:477-499, 1997
122. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348:2543-2556, 2003
123. Jalalah SM, Alzahrani IH, Furness PN: Glomerular changes in microscopic haematuria, studied by quantitative immunoelectron microscopy and in situ zymography. Nephrol Dial Transplant 17:1586-1593, 2002
124. Nieuwhof CM, de Heer F, de Leeuw P, van Breda Vriesman PJ: Thin GBM nephropathy: Premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int 51:1596-1601, 1997
125. Gandhi S, Kalantar-Zadeh K, Don BR: Thin-glomerular-basement-membrane nephropathy: Is it a benign cause of isolated hematuria? South Med J 95:768-771, 2002
126. Liapis H, Gokden N, Hmiel P, Miner JH: Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants. Hum Pathol 33:836-845, 2002
127. Dische FE, Weston MJ, Parsons V: Abnormally thin glomerular basement membranes associated with hematuria, proteinuria or renal failure in adults. Am J Nephrol 5:103-109, 1985
128. Piel CF, Biava CG, Goodman JR: Glomerular basement membrane attenuation in familial nephritis and "benign" hematuria. J Pediatr 101:358-365, 1982
129. Auwardt R, Savige J, Wilson D: A comparison of the clinical and laboratory features of thin basement membrane disease (TBMD) and IgA glomerulonephritis (IgA GN). Clin Nephrol 52:1-4, 1999
130. Piel CF, Biava CG, Goodman JR: Glomerular basement membrane attenuation in familial nephritis and "benign" hematuria. J Pediatr 101:358-365, 1982
131. Dische FE, Anderson VE, Keane SJ, Taube D, Bewick M, Parsons V: Incidence of thin membrane nephropathy: Morphometric investigation of a population sample. J Clin Pathol 43:457-460, 1990
132. Dische FE: Measurement of glomerular basement membrane thickness and its application to the diagnosis of thin-membrane nephropathy. Arch Pathol Lab Med 116:43-49, 1992
133. Nicolau C, Torra R, Badenas C, et al: Autosomal dominant polycystic kidney disease type 1 and 2: Assessment of US sensitivity for diagnosis. Radiology 213:273-276, 1999
134. Zand MS, Strang J, Dumlao M, Rubens D, Erturk E, Bronsther O: Screening a living kidney donor for polycystic kidney disease using heavily T2-weighted MRI. Am J Kidney Dis 37:612-619, 2001
135. Rossetti S, Chauveau D, Walker D, et al: A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int 61:1588-1599, 2002
136. Rossetti S, Chauveau D, Kubly V, et al: Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361:2196-2201, 2003
137. Rossetti S, Torra R, Coto E, et al: A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int 64:391-403, 2003
138. Magistroni R, He N, Wang K, et al: Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 14:1164-1174, 2003
139. Phakdeekitcharoen B, Watnick TJ, Germino GG: Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. J Am Soc Nephrol 12:955-963, 2001
140. Kasiske BL, Bia MJ: The evaluation and selection of living kidney donors. Am J Kidney Dis 26:387-398, 1995
141. Kasiske BL, Ravenscraft M, Ramos EL, Gastron RS, Bia MJ, Danovitch GM: The evaluation of living renal transplant donors: Clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 7:2288-2313, 1996
142. Horia M, Orita Y, Fukunaga M: Assessment of renal function, in Johnson RJ, Feehally J (eds): Comprehensive Clinical Nephrology. London, UK, Mosby, 2003, pp 27-34
143. Johnson RJ, Feehally J (eds): Comprehensive Clinical Nephrology (ed 2). Chapter 3. St Louis, MO, Mosby, 2003, p 33